Pliant Therapeutics

PLRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$68.733 M

$1.11 +0.00%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

$149.3M

#1127 by earnings

Shares outstanding

61,921,897

Latest filing cover page

P/E ratio

0.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#332Gossamer BioGOSS$69.0M
#333Alterity TherapeuticsATHE$68.8M
#334Pliant TherapeuticsPLRX$68.7M
#335Rein TherapeuticsRNTX$68.5M
#336XBiotechXBIT$66.5M

What if Pliant Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$488,907.08

Per share 440,457× higher

Bitcoin $1.72T

$27,773.76

Per share 25,021× higher

Nvidia $5.48T

$88,496.29

Per share 79,726× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Pliant Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.